Title |
Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses
|
---|---|
Published in |
PLOS ONE, May 2014
|
DOI | 10.1371/journal.pone.0094883 |
Pubmed ID | |
Authors |
Catherine Gérard, Nathalie Baudson, Thierry Ory, Jamila Louahed |
Abstract |
MAGE-A3 is a potential target for immunotherapy due to its tumor-specific nature and expression in several tumor types. Clinical data on MAGE-A3 immunotherapy have raised many questions that can only be addressed by using animal models. In the present study, different aspects of the murine anti-tumor immune responses induced by a recombinant MAGE-A3 protein (recMAGE-A3) in combination with different immunostimulants (AS01, AS02, CpG7909 or AS15) were investigated. |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 22% |
Student > Bachelor | 5 | 14% |
Researcher | 5 | 14% |
Other | 2 | 6% |
Student > Master | 2 | 6% |
Other | 4 | 11% |
Unknown | 10 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 17% |
Medicine and Dentistry | 5 | 14% |
Immunology and Microbiology | 4 | 11% |
Agricultural and Biological Sciences | 3 | 8% |
Chemistry | 2 | 6% |
Other | 6 | 17% |
Unknown | 10 | 28% |